Tirzepatide (Mounjaro)-induced acute pancreatitis and ketoacidosis in an adult nondiabetic patient
Tirzepatide (Mounjaro) is a new medication approved for type 2 diabetes and obesity treatment. It works by activating the receptors for both glucose-dependent insulinotropic peptide and glucagon-like peptide-1. Side effects due to tirzepatide are typically gastrointestinal in nature and self-resolvi...
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Серія: | Saudi Journal for Health Sciences |
| Предмети: | |
| Онлайн доступ: | https://journals.lww.com/10.4103/sjhs.sjhs_122_24 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|